{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:42:29Z","timestamp":1788950549035,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["A18-1052"],"award-info":[{"award-number":["A18-1052"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["A18-1052"],"award-info":[{"award-number":["A18-1052"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["A18-1052"],"award-info":[{"award-number":["A18-1052"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["A18-1052"],"award-info":[{"award-number":["A18-1052"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-025-03914-5","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:13:12Z","timestamp":1739279592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Distinct metabolic perturbations link liver steatosis and incident CVD in lean but not obese PWH"],"prefix":"10.1186","volume":"23","author":[{"given":"Louise E.","family":"van Eekeren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Vadaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc J. T.","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert L.","family":"Groenendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm A. J. W.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erni J.","family":"Nelwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies","family":"Verbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke E.","family":"Stalenhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin A. H.","family":"Berrevoets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"van Lunzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihai G.","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Weijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels P.","family":"Riksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost H. W.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quirijn","family":"de Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric T. T. L.","family":"Tjwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A. B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 J. A. M.","family":"van der Ven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"9939","key":"3914_CR1","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(14)60604-8","volume":"384","author":"CJ Smith","year":"2014","unstructured":"Smith CJ, Ryom L, Weber R, Morlat P, Pradier C, Reiss P, et al. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration. Lancet. 2014;384(9939):241\u20138.","journal-title":"Lancet"},{"issue":"3","key":"3914_CR2","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1016\/S2352-3018(22)00400-3","volume":"10","author":"E Verheij","year":"2023","unstructured":"Verheij E, Boyd A, Wit FW, Verboeket SO, Verburgh ML, van der Valk M, et al. Long-term evolution of comorbidities and their disease burden in individuals with and without HIV as they age: analysis of the prospective AGE(h)IV cohort study. Lancet HIV. 2023;10(3):e164\u201374.","journal-title":"Lancet HIV"},{"issue":"6","key":"3914_CR3","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"1","key":"3914_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"key":"3914_CR5","doi-asserted-by":"crossref","unstructured":"Paik JM, Henry L, Golabi P, Alqahtani SA, Trimble G, Younossi ZM. Presumed nonalcoholic fatty liver disease among medicare beneficiaries with HIV, 2006\u20132016. Open Forum Infect Dis. 2020;7(1):ofz509.","DOI":"10.1093\/ofid\/ofz509"},{"issue":"10290","key":"3914_CR6","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324.","journal-title":"Lancet"},{"key":"3914_CR7","doi-asserted-by":"crossref","unstructured":"Krishnan A, Sims OT, Surapaneni PK, Woreta TA, Alqahtani SA. Risk of adverse cardiovascular outcomes among persons living with HIV and nonalcoholic fatty liver disease: a multicenter matched cohort study. AIDS. 2023.","DOI":"10.1097\/QAD.0000000000003537"},{"issue":"3","key":"3914_CR8","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","volume":"65","author":"G Targher","year":"2016","unstructured":"Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65(3):589\u2013600.","journal-title":"J Hepatol"},{"key":"3914_CR9","doi-asserted-by":"publisher","first-page":"102292","DOI":"10.1016\/j.eclinm.2023.102292","volume":"65","author":"JH Moon","year":"2023","unstructured":"Moon JH, Jeong S, Jang H, Koo BK, Kim W. Metabolic dysfunction-associated steatotic liver disease increases the risk of incident cardiovascular disease: a nationwide cohort study. EClinicalMedicine. 2023;65: 102292.","journal-title":"EClinicalMedicine"},{"issue":"4","key":"3914_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/QAI.0000000000002359","volume":"84","author":"A Kaplan","year":"2020","unstructured":"Kaplan A, Simon TG, Henson JB, Wang T, Zheng H, Osganian SA, et al. Brief report: relationship between nonalcoholic fatty liver disease and cardiovascular disease in persons with HIV. J Acquir Immune Defic Syndr. 2020;84(4):400\u20134.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"3914_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.5009\/gnl210084","volume":"16","author":"Y Kim","year":"2022","unstructured":"Kim Y, Han E, Lee JS, Lee HW, Kim BK, Kim MK, et al. Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease. Gut Liver. 2022;16(2):290\u20139.","journal-title":"Gut Liver"},{"issue":"6","key":"3914_CR12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1007\/s11904-023-00669-7","volume":"20","author":"K Wegermann","year":"2023","unstructured":"Wegermann K, Moylan C, Naggie S. Fatty liver disease: enter the metabolic era. Curr HIV\/AIDS Rep. 2023;20(6):405\u201318.","journal-title":"Curr HIV\/AIDS Rep"},{"key":"3914_CR13","doi-asserted-by":"publisher","first-page":"103548","DOI":"10.1016\/j.ebiom.2021.103548","volume":"71","author":"Y Ding","year":"2021","unstructured":"Ding Y, Lin H, Chen X, Zhu B, Xu X, Xu X, et al. Comprehensive metabolomics profiling reveals common metabolic alterations underlying the four major non-communicable diseases in treated HIV infection. EBioMedicine. 2021;71: 103548.","journal-title":"EBioMedicine"},{"issue":"1","key":"3914_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1210\/clinem\/dgab663","volume":"107","author":"J Jao","year":"2022","unstructured":"Jao J, Balmert LC, Sun S, McComsey GA, Brown TT, Tien PC, et al. Distinct lipidomic signatures in people living with HIV: combined analysis of ACTG 5260s and MACS\/WIHS. J Clin Endocrinol Metab. 2022;107(1):119\u201335.","journal-title":"J Clin Endocrinol Metab"},{"key":"3914_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1471-2334-13-203","volume":"13","author":"E Cassol","year":"2013","unstructured":"Cassol E, Misra V, Holman A, Kamat A, Morgello S, Gabuzda D. Plasma metabolomics identifies lipid abnormalities linked to markers of inflammation, microbial translocation, and hepatic function in HIV patients receiving protease inhibitors. BMC Infect Dis. 2013;13:203.","journal-title":"BMC Infect Dis"},{"key":"3914_CR16","doi-asserted-by":"crossref","unstructured":"Ueland T, Waagsbo B, Berge RK, Troseid M, Aukrust P, Damas JK. Fatty acids composition and HIV infection: altered levels of n-6 polyunsaturated fatty acids are associated with disease progression. Viruses. 2023;15(7).","DOI":"10.3390\/v15071613"},{"key":"3914_CR17","doi-asserted-by":"publisher","first-page":"982746","DOI":"10.3389\/fimmu.2022.982746","volume":"13","author":"W Vos","year":"2022","unstructured":"Vos W, Groenendijk AL, Blaauw MJT, van Eekeren LE, Navas A, Cleophas MCP, et al. The 2000HIV study: design, multi-omics methods and participant characteristics. Front Immunol. 2022;13: 982746.","journal-title":"Front Immunol"},{"issue":"9","key":"3914_CR18","doi-asserted-by":"publisher","first-page":"e022516","DOI":"10.1136\/bmjopen-2018-022516","volume":"8","author":"TS Boender","year":"2018","unstructured":"Boender TS, Smit C, Sighem AV, Bezemer D, Ester CJ, Zaheri S, et al. AIDS Therapy Evaluation in the Netherlands (ATHENA) national observational HIV cohort: cohort profile. BMJ Open. 2018;8(9): e022516.","journal-title":"BMJ Open"},{"issue":"20","key":"3914_CR19","doi-asserted-by":"publisher","first-page":"e030606","DOI":"10.1161\/JAHA.123.030606","volume":"12","author":"MJT Blaauw","year":"2023","unstructured":"Blaauw MJT, Berrevoets MAH, Vos WAJW, Groenendijk AL, van Eekeren LE, Vadaq N, et al. Traditional cardiovascular risk factors are stronger related to carotid intima-media thickness than to presence of carotid plaques in people living with HIV. J Am Heart Assoc. 2023;12(20): e030606.","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"3914_CR20","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D'Agostino","year":"2008","unstructured":"D\u2019Agostino RB, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743\u201353.","journal-title":"Circulation"},{"key":"3914_CR21","doi-asserted-by":"crossref","unstructured":"collaboration SwgaECr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354.","DOI":"10.1093\/eurheartj\/ehab309"},{"key":"3914_CR22","doi-asserted-by":"crossref","unstructured":"van Eekeren LE, Vadaq N, Vos WAJW, Blaauw MJT, Groenendijk AL, van Lunzen J, et al. Liver steatosis is prevalent in lean people with HIV and associated with exposure to antiretroviral treatment-a cross-sectional study. Open Forum Infect Dis. 2024;11(6):ofae266.","DOI":"10.1093\/ofid\/ofae266"},{"issue":"5","key":"3914_CR23","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1111\/apt.17849","volume":"59","author":"S Gawrieh","year":"2024","unstructured":"Gawrieh S, Vilar-Gomez E, Woreta TA, Lake JE, Wilson LA, Price JC, et al. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Aliment Pharmacol Ther. 2024;59(5):666\u201379.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3914_CR24","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.cgh.2018.04.043","volume":"17","author":"MS Siddiqui","year":"2019","unstructured":"Siddiqui MS, Vuppalanchi R, Van Natta ML, Hallinan E, Kowdley KV, Abdelmalek M, et al. Vibration-controlled transient elastography to assess fibrosis and steatosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2019;17(1):156-63.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"3914_CR25","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/hep.23312","volume":"51","author":"VW Wong","year":"2010","unstructured":"Wong VW, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, et al. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Hepatology. 2010;51(2):454\u201362.","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"3914_CR26","first-page":"51S","volume":"6","author":"Clinical guidelines on the identification","year":"1998","unstructured":"Clinical guidelines on the identification. evaluation, and treatment of overweight and obesity in adults\u2013the evidence report. National Institutes of Health Obes Res. 1998;6(Suppl 2):51S-209S.","journal-title":"National Institutes of Health Obes Res"},{"issue":"3","key":"3914_CR27","first-page":"370","volume":"17","author":"WH Pan","year":"2008","unstructured":"Pan WH, Yeh WT. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008;17(3):370\u20134.","journal-title":"Asia Pac J Clin Nutr"},{"issue":"18","key":"3914_CR28","doi-asserted-by":"publisher","first-page":"7074","DOI":"10.1021\/ac201267k","volume":"83","author":"T Fuhrer","year":"2011","unstructured":"Fuhrer T, Heer D, Begemann B, Zamboni N. High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. Anal Chem. 2011;83(18):7074\u201380.","journal-title":"Anal Chem"},{"issue":"1","key":"3914_CR29","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen P, Kangas AJ, Wurtz P, Suna T, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ Cardiovasc Genet. 2015;8(1):192\u2013206.","journal-title":"Circ Cardiovasc Genet"},{"issue":"9","key":"3914_CR30","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P Wurtz","year":"2017","unstructured":"Wurtz P, Kangas AJ, Soininen P, Lawlor DA, Davey Smith G, Ala-Korpela M. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies. Am J Epidemiol. 2017;186(9):1084\u201396.","journal-title":"Am J Epidemiol"},{"key":"3914_CR31","doi-asserted-by":"crossref","unstructured":"Pang Z, Lu Y, Zhou G, Hui F, Xu L, Viau C, et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024.","DOI":"10.1093\/nar\/gkae253"},{"issue":"7","key":"3914_CR32","doi-asserted-by":"publisher","first-page":"e1003123","DOI":"10.1371\/journal.pcbi.1003123","volume":"9","author":"S Li","year":"2013","unstructured":"Li S, Park Y, Duraisingham S, Strobel FH, Khan N, Soltow QA, et al. Predicting network activity from high throughput metabolomics. PLoS Comput Biol. 2013;9(7): e1003123.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"3914_CR33","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s12944-024-02265-z","volume":"23","author":"TC Lin","year":"2024","unstructured":"Lin TC, Huang CY, Li YL, Chiou HY, Hu CJ, Jeng JS, et al. Association between high-density lipoprotein and functional outcome of ischemic stroke patients in a Taiwanese population. Lipids Health Dis. 2024;23(1):275.","journal-title":"Lipids Health Dis"},{"key":"3914_CR34","doi-asserted-by":"publisher","first-page":"1065750","DOI":"10.3389\/fcvm.2023.1065750","volume":"10","author":"Y Huang","year":"2023","unstructured":"Huang Y, Yan MQ, Zhou D, Chen CL, Feng YQ. The U-shaped association of non-high-density lipoprotein cholesterol with all-cause and cardiovascular mortality in general adult population. Front Cardiovasc Med. 2023;10:1065750.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3914_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.5114\/ceh.2023.130744","volume":"9","author":"AE Platek","year":"2023","unstructured":"Platek AE, Szymanska A. Metabolic dysfunction-associated steatotic liver disease as a cardiovascular risk factor. Clin Exp Hepatol. 2023;9(3):187\u201392.","journal-title":"Clin Exp Hepatol"},{"key":"3914_CR36","doi-asserted-by":"crossref","unstructured":"Barchetta I, Cimini FA, Cavallo MG. Vitamin D and metabolic dysfunction-associated fatty liver disease (MAFLD): an update. Nutrients. 2020;12(11).","DOI":"10.3390\/nu12113302"},{"key":"3914_CR37","doi-asserted-by":"crossref","unstructured":"Leonetti S, Herzog RI, Caprio S, Santoro N, Tric\u00f2 D. Glutamate-serine-glycine index: a novel potential biomarker in pediatric non-alcoholic fatty liver disease. Children (Basel). 2020;7(12).","DOI":"10.3390\/children7120270"},{"key":"3914_CR38","doi-asserted-by":"publisher","first-page":"582680","DOI":"10.3389\/fphar.2020.582680","volume":"11","author":"W Yu","year":"2020","unstructured":"Yu W, Cheng JD. Uric acid and cardiovascular disease: an update from molecular mechanism to clinical perspective. Front Pharmacol. 2020;11: 582680.","journal-title":"Front Pharmacol"},{"key":"3914_CR39","doi-asserted-by":"crossref","unstructured":"Sonnweber T, Pizzini A, Nairz M, Weiss G, Tancevski I. Arachidonic acid metabolites in cardiovascular and metabolic diseases. Int J Mol Sci. 2018;19(11).","DOI":"10.3390\/ijms19113285"},{"key":"3914_CR40","doi-asserted-by":"crossref","unstructured":"Zhou Y, Khan H, Xiao J, Cheang WS. Effects of arachidonic acid metabolites on cardiovascular health and disease. Int J Mol Sci. 2021;22(21).","DOI":"10.3390\/ijms222112029"},{"issue":"1","key":"3914_CR41","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1038\/s41598-024-55845-5","volume":"14","author":"X Yang","year":"2024","unstructured":"Yang X, Lin Y, Huang J, Chi Y, Wu Y, Lin S. Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease. Sci Rep. 2024;14(1):5923.","journal-title":"Sci Rep"},{"key":"3914_CR42","doi-asserted-by":"crossref","unstructured":"Dalli J, Kitch D, O'Brien MP, Hunt PW, Funderburg N, Moisi D, et al. Pro-inflammatory and pro-resolving lipid mediators of inflammation in HIV: effect of aspirin intervention. EBioMedicine. 2023;89:104468.","DOI":"10.1016\/j.ebiom.2023.104468"},{"issue":"11","key":"3914_CR43","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1097\/01.aids.0000237374.16068.de","volume":"20","author":"UA Walker","year":"2006","unstructured":"Walker UA, Hoffmann C, Enters M, Thoden J, Behrens G, Mitzel SL. High serum urate in HIV-infected persons: the choice of the antiretroviral drug matters. AIDS. 2006;20(11):1556\u20138.","journal-title":"AIDS"},{"issue":"1","key":"3914_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12981-019-0226-2","volume":"16","author":"P Maggi","year":"2019","unstructured":"Maggi P, De Socio GV, Cicalini S, D\u2019Abbraccio M, Dettorre G, Di Biagio A, et al. Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use. AIDS Res Ther. 2019;16(1):11.","journal-title":"AIDS Res Ther"},{"issue":"11","key":"3914_CR45","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1001\/jama.2024.1215","volume":"331","author":"TG Simon","year":"2024","unstructured":"Simon TG, Wilechansky RM, Stoyanova S, Grossman A, Dichtel LE, Lauer GM, et al. Aspirin for metabolic dysfunction-associated steatotic liver disease without cirrhosis: a randomized clinical trial. JAMA. 2024;331(11):920\u20139.","journal-title":"JAMA"},{"key":"3914_CR46","doi-asserted-by":"publisher","first-page":"102065","DOI":"10.1016\/j.eclinm.2023.102065","volume":"61","author":"TY Lee","year":"2023","unstructured":"Lee TY, Hsu YC, Ho HJ, Lin JT, Chen YJ, Wu CY. Daily aspirin associated with a reduced risk of hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: a population-based cohort study. EClinicalMedicine. 2023;61: 102065.","journal-title":"EClinicalMedicine"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-025-03914-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-025-03914-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:13:18Z","timestamp":1739279598000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-025-03914-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3914"],"URL":"https:\/\/doi.org\/10.1186\/s12916-025-03914-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"4 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The 2000-HIV study was approved by the Independent Review Board Nijmegen (ref. NL68056.091.81) and the study protocol was published at clinicaltrials.gov (ID: NCT03994835). Written informed consent was obtained from all study participants and experiments were conducted according to the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}